In-Silico testing and validation of Cardiovascular IMplantable devices Read more

SIMCor is a three-and-a-half-year (January 2021 - June 2024) Horizon 2020 research and innovation action developing a computational platform for in-silico development, validation and regulatory approval of cardiovascular implantable devices

Objective 1

Provide proof-of-validation for virtual cohorts and computer-based simulation of cardiovascular device implantation and performance

Objective 2

Develop standards and protocols for in-silico testing and validation of cardiovascular devices

Objective 3

Quantify the benefits of in-silico testing for healthcare, industry and society as a whole

Objective 4

Accelerate the integration of in-silico testing into the medical device regulatory approval process, the market and the clinics

Objective 5

Contribute to the European Open Science Cloud with data, virtual cohorts, simulation models, methodologies, standards and guidelines

Device effect simulation domain of the SIMCor VRE.

Strong international visitor attendance at MEDICA + COMPAMED in Düsseldorf © Constanze Tillmann/ Messe Düsseldorf via

Vienna State Opera at night. Credits: Pierre Blaché, CC0, via Wikimedia Commons

San Francisco city skyline. Credits: Lisafern, CC0, via Wikimedia Commons.

Image credits: Andreas Ardnt, Biotronik